Literature DB >> 22572688

Is it diverticular disease or is it irritable bowel syndrome?

Robin Spiller1.   

Abstract

Symptomatic diverticular disease (SYMP-DD) and irritable bowel syndrome (IBS) share many features. Both are characterised by recurrent episodes of abdominal pain which may be slightly more frequent in IBS than SYMP-DD. They may also both exhibit an erratic bowel habit with diarrhoea, constipation and alternating types. It is important to assess anxiety, depression and somatisation since this can be increased in both types of patients and may be associated with visceral hypersensitivity. There are also significant differences between IBS and SYMP-DD. In particular, SYMP-DD patients are older, lack the female predominance seen in IBS and may often have fever with prolonged episodes of pain. For them, abnormalities of the gut are probably more important than cerebral factors, while for IBS the reverse is true. Treatments should be directed at the predominant abnormality which will vary in every patient.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22572688     DOI: 10.1159/000335721

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  20 in total

1.  Italian consensus conference for colonic diverticulosis and diverticular disease.

Authors:  Rosario Cuomo; Giovanni Barbara; Fabio Pace; Vito Annese; Gabrio Bassotti; Gian Andrea Binda; Tino Casetti; Antonio Colecchia; Davide Festi; Roberto Fiocca; Andrea Laghi; Giovanni Maconi; Riccardo Nascimbeni; Carmelo Scarpignato; Vincenzo Villanacci; Bruno Annibale
Journal:  United European Gastroenterol J       Date:  2014-10       Impact factor: 4.623

2.  Incidence and predictive factors of irritable bowel syndrome after acute diverticulitis in Korea.

Authors:  Sungmo Jung; Hyuk Lee; Hyunsoo Chung; Jun Chul Park; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee
Journal:  Int J Colorectal Dis       Date:  2014-09-26       Impact factor: 2.571

Review 3.  Management of sigmoid diverticulitis: an update.

Authors:  Patrick Ambrosetti; Pascal Gervaz
Journal:  Updates Surg       Date:  2016-04-16

4.  Practice parameters for the treatment of colonic diverticular disease: Italian Society of Colon and Rectal Surgery (SICCR) guidelines.

Authors:  G A Binda; R Cuomo; A Laghi; R Nascimbeni; A Serventi; D Bellini; P Gervaz; B Annibale
Journal:  Tech Coloproctol       Date:  2015-09-16       Impact factor: 3.781

5.  A randomized double-blind placebo-controlled trial of a multi-strain probiotic in treatment of symptomatic uncomplicated diverticular disease.

Authors:  Charlotte L Kvasnovsky; Ingvar Bjarnason; Ana Nora Donaldson; Roy A Sherwood; Savvas Papagrigoriadis
Journal:  Inflammopharmacology       Date:  2017-05-20       Impact factor: 4.473

Review 6.  [Diverticular disease - diagnosis and classification].

Authors:  B Lembcke
Journal:  Chirurg       Date:  2014-04       Impact factor: 0.955

7.  Colonic Diverticula Are Not Associated With Mucosal Inflammation or Chronic Gastrointestinal Symptoms.

Authors:  Anne F Peery; Temitope O Keku; Cassandra Addamo; Amber N McCoy; Christopher F Martin; Joseph A Galanko; Robert S Sandler
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-08       Impact factor: 11.382

Review 8.  Colonic smooth muscle cells and colonic motility patterns as a target for irritable bowel syndrome therapy: mechanisms of action of otilonium bromide.

Authors:  Jakub Rychter; Francisco Espín; Diana Gallego; Patri Vergara; Marcel Jiménez; Pere Clavé
Journal:  Therap Adv Gastroenterol       Date:  2014-07       Impact factor: 4.409

9.  Disease phenotype rather than treatment strategy impacts the long-term quality of life in patients with diverticular disease.

Authors:  Maximilian Sohn; A Agha; D Roussos; F Bloss; A Hochrein; F Gundling; I Iesalnieks
Journal:  Int J Colorectal Dis       Date:  2019-09-06       Impact factor: 2.571

Review 10.  Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon.

Authors:  Eleonora Scaioli; Antonio Colecchia; Giovanni Marasco; Ramona Schiumerini; Davide Festi
Journal:  Dig Dis Sci       Date:  2015-10-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.